BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 26564073)

  • 1. Tuberous sclerosis complex.
    Islam MP; Roach ES
    Handb Clin Neurol; 2015; 132():97-109. PubMed ID: 26564073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberous sclerosis complex.
    Hasbani DM; Crino PB
    Handb Clin Neurol; 2018; 148():813-822. PubMed ID: 29478616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tuberous sclerosis complex: A review].
    Pfirmann P; Combe C; Rigothier C
    Rev Med Interne; 2021 Oct; 42(10):714-721. PubMed ID: 33836894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex.
    MacKeigan JP; Krueger DA
    Neuro Oncol; 2015 Dec; 17(12):1550-9. PubMed ID: 26289591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberous sclerosis complex.
    Henske EP; Jóźwiak S; Kingswood JC; Sampson JR; Thiele EA
    Nat Rev Dis Primers; 2016 May; 2():16035. PubMed ID: 27226234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberous sclerosis: a review of the past, present, and future.
    Uysal SP; Şahin M
    Turk J Med Sci; 2020 Nov; 50(SI-2):1665-1676. PubMed ID: 32222129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Care continuity for patients with tuberous sclerosis complex (TSC) during transition from childhood to adulthood].
    Kiyoko S; Hitoshi O
    Nihon Rinsho; 2010 Jan; 68(1):136-40. PubMed ID: 20077806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Missense mutations to the TSC1 gene cause tuberous sclerosis complex.
    Nellist M; van den Heuvel D; Schluep D; Exalto C; Goedbloed M; Maat-Kievit A; van Essen T; van Spaendonck-Zwarts K; Jansen F; Helderman P; Bartalini G; Vierimaa O; Penttinen M; van den Ende J; van den Ouweland A; Halley D
    Eur J Hum Genet; 2009 Mar; 17(3):319-28. PubMed ID: 18830229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas.
    Plank TL; Logginidou H; Klein-Szanto A; Henske EP
    Mod Pathol; 1999 May; 12(5):539-45. PubMed ID: 10349994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.
    Astrinidis A; Henske EP
    Oncogene; 2005 Nov; 24(50):7475-81. PubMed ID: 16288294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberous sclerosis complex.
    DiMario FJ; Sahin M; Ebrahimi-Fakhari D
    Pediatr Clin North Am; 2015 Jun; 62(3):633-48. PubMed ID: 26022167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.
    Feliciano DM; Lin TV; Hartman NW; Bartley CM; Kubera C; Hsieh L; Lafourcade C; O'Keefe RA; Bordey A
    Int J Dev Neurosci; 2013 Nov; 31(7):667-78. PubMed ID: 23485365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Everolimus improves neuropsychiatric symptoms in a patient with tuberous sclerosis carrying a novel TSC2 mutation.
    Hwang SK; Lee JH; Yang JE; Lim CS; Lee JA; Lee YS; Lee K; Kaang BK
    Mol Brain; 2016 May; 9(1):56. PubMed ID: 27216612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tuberous sclerosis genes and regulation of the cyclin-dependent kinase inhibitor p27.
    Rosner M; Freilinger A; Hengstschläger M
    Mutat Res; 2006 Sep; 613(1):10-6. PubMed ID: 16713332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberous sclerosis complex and DNA repair.
    Habib SL
    Adv Exp Med Biol; 2010; 685():84-94. PubMed ID: 20687497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin as a therapy of choice after renal transplantation in a patient with tuberous sclerosis complex.
    Tarasewicz A; Debska-Slizień A; Konopa J; Zdrojewski Z; Rutkowski B
    Transplant Proc; 2009 Nov; 41(9):3677-82. PubMed ID: 19917366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy.
    Curatolo P
    Pediatr Neurol; 2015 Mar; 52(3):281-9. PubMed ID: 25591831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathogenesis of tuber formation in tuberous sclerosis complex.
    Crino PB
    J Child Neurol; 2004 Sep; 19(9):716-25. PubMed ID: 15563019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberous sclerosis as an underlying basis for infantile spasm.
    Yeung RS
    Int Rev Neurobiol; 2002; 49():315-32. PubMed ID: 12040899
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.